Table 5.
Autoantibodies and autoimmunity profile of the 59 pSS criteria patients: comparison between patients with and without an SGU pSS pattern.
|
Total |
Pathological SGU |
Normal SGU |
p | |
|---|---|---|---|---|
| n = 59 | n = 32 | n = 28 | ||
| Complete positive group | 36 (61.0) | 25 (80.6) | 11 (39.3) | 0.001 |
| Partial seropositive group | 23 (39.0) | 6 (19.4) | 17 (60.7) | |
| Negative group | ||||
| ANA + (n = 59) | 58 (98.3) | 31 (100.0) | 27 (96.4) | 0.475 |
| RF + (n = 59) | 46 (78.0) | 27 (87.1) | 19 (67.9) | 0.075 |
| Anti-SSA/Ro + (n = 58) | 46 (79.3) | 27 (87.1) | 19 (70.4) | 0.117 |
| Anti-SSB/La + (n = 55) | 28 (50.9) | 19 (65.5) | 9 (34.6) | 0.022 |
Data are presented as n (%).
pSS: primary Sjögren’s syndrome; SGU: salivary gland ultrasound; ANA: antinuclear antibodies; RF: rheumatoid factor
Analysis of residuals: cells with more (↑) or fewer (↓) observed patients than expected under the independence hypothesis (p < 0.05).